Rooting for Remdesivir; Pharmaceuticals & the Push for Progress

Gilead’s experimental Covid-19 treatment caught the markets’ attention after STAT News reported encouraging early results in its phase 3 trial. Former FDA Commissioner Dr. Scott Gottlieb explains the antiviral Remdesivir and explains its potential role in flattening the pandemic’s curve. French pharmaceutical company Sanofi has partnered with peer GlaxoSmithKline to develop a Covid-19 vaccine in the next 18 months. Sanofi has also partnered with a startup to create a coronavirus test using a smartphone. CEO Paul Hudson explains the news, the technology, and the path ahead for a healthier planet.